GPX7 and gastric cancer: In contrast to all seven gastric cancer cell lines and 56% (25/45) of gastric cancer samples, only 13% (6/45) of normal samples showed DNA hypermethylation (>10% methylation level) of the GPX7 promoter (P < 0.0001).